SCHEMBL30774601

SCHEMBL30774601

O=C(C1CN(Cc2cccc(F)c2)C1)N1CCOc2c(N3CCn4cnnc4C3)cncc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ HPGD P15428 1/20 0.38
▸ MAPT P10636 1/20 0.35
▸ MAOB P27338 1/20 0.35
▸ CDK9 P50750 1/20 0.34
▸ MEN1 O00255 3/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ FAAH O00519 1/20 0.34
▸ NAAA Q02083 1/20 0.34
▸ HTR1A P08908 2/20 0.34
▸ DRD2 P14416 2/20 0.34
▸ DRD4 P21917 1/20 0.34
▸ HTR2A P28223 1/20 0.34
▸ HTR7 P34969 1/20 0.34
▸ DRD3 P35462 1/20 0.34
▸ HTR2B P41595 1/20 0.34
▸ EED O75530 1/20 0.33
▸ HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30774666 0.89 ALDH1A1 (0.37) ALDH1A1KDM4EHPGDMAPTMAOB
SCHEMBL30774568 0.83 USP30 (0.41) ALDH1A1KDM4EHPGDMAPTMAOB
SCHEMBL30774472 0.81 ALDH1A1 (0.43) ALDH1A1KDM4EHPGDMAPTMAOB
SCHEMBL30774429 0.79 USP30 (0.39) ALDH1A1KDM4EHPGDMAPTMAOB
SCHEMBL30774480 0.76 USP30 (0.39) ALDH1A1KDM4EHPGDMAPTMAOB
SCHEMBL30774750 0.76 ALDH1A1 (0.48) ALDH1A1KDM4EHPGDMAPTMEN1
SCHEMBL31635551 0.76 ALDH1A1 (0.48) ALDH1A1KDM4EHPGDMAPTMEN1
SCHEMBL30774590 0.75 USP30 (0.42) ALDH1A1KDM4EHPGDMAOB
SCHEMBL30774521 0.74 ALDH1A1 (0.38) ALDH1A1KDM4EHPGDMAPTMAOB
SCHEMBL30774010 0.74 ALDH1A1 (0.38) ALDH1A1KDM4EHPGDMAPTMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260092074-A1 Annelated Pyridines as Steroidogenesis Inhibitors, Preparation Method and Use Thereof GUANGZHOU VINNOCENT PHARMACEUTICAL LTD (CN) 2026-04-02 — — US claimed
EP-4574830-A1 ANNELATED PYRIDINE STEROID SYNTHETASE INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF Guangzhou Vinnocent Pharmaceutical Limited (CN) 2025-06-25 — — EP claimed
US-20260092074-A1 Annelated Pyridines as Steroidogenesis Inhibitors, Preparation Method and Use Thereof GUANGZHOU VINNOCENT PHARMACEUTICAL LTD (CN) 2026-04-02 — — US disclosed
EP-4574830-A1 ANNELATED PYRIDINE STEROID SYNTHETASE INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF Guangzhou Vinnocent Pharmaceutical Limited (CN) 2025-06-25 — — EP disclosed
WO-2024061371-A1 ANNELATED PYRIDINE STEROID SYNTHETASE INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF 广州威诺森医药科技有限公司 2024-03-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260092074-A1 Annelated Pyridines as Steroidogenesis Inhibitors, Preparation Method and Use Thereof STS, NR5A1, CYP21A2 ALDH1A1 610/4885KDM4E 1112/4885HPGD 1617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback